Overview
- Description
The company is a biotech company pioneering ultra high-throughput therapeutic discovery by leveraging single-cell analysis to develop new immune therapies.
- Website
- Press Release
- Country
- Ireland
- Sector
- Health Biotechnology
"RemedyBio continues to grow, following the business acceleration gained through EIC grant and blended finance funding. As our strategy evolves to look at further opportunities around our Nanoreactor Technology and Searchlight Discovery Platform, we will continue to identify and develop new efficacious therapies for hard-to-treat diseases."
Dan Crowley, CEO
